AzTrials
AzTrials

Mechanical Complication of Coronary Artery Bypass GraftOSTinCARENCT01714791

Effects of Osteopathic Treatment on Pulmonary Function After Coronary Artery Bypass Graft Surgery

A study testing Osteopathic treatment in people with Mechanical Complication of Coronary Artery Bypass Graft and Respiratory Depression, run by Hartcentrum Hasselt at 1 site in Belgium.

Terminated

Stopped early. The study ended before it was planned to and will not resume.

Official record
Search all trials

Trial summary

The purpose of this study is to determine the short and long term effects of osteopathic treatment on pulmonary function, pain and quality of life in patients after coronary artery bypass graft (CABG) surgery. The study is a randomized controlled trial. Read more about this study

Who is it for?
Any age
What is being tested?
Osteopathic treatment
Could I receive a placebo?
No, everyone receives an active treatment
How many people
112 participants
Where
1 siteBelgium
Study dates
Jan 2010to Dec 2017
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages Any age
  • All sexes
  • No healthy volunteers
  • Child, Adult, Older adult

Who may be able to join

  • Planned Coronary Artery Bypass Graft (CABG) surgery at the Jessa Hospital Hasselt
  • Planned Endoscopic Atraumatic Coronary Artery Bypass (endo ACAB) surgery at the Jessa Hospital
  • Planned Minimal Invasive Aortic Valve Replacement (mini AVR) surgery at the Jessa Hospital

Who cannot join

  • Thoracic surgery in the past
  • Redo CABG
  • Complications after CABG, requiring long-term (more than 6 days) admission to intensive care
  • Pathologies of the lungs
  • Pathologies of the heart, other than the coronary artery disease
  • Surgery in the sub diaphragmatic region: epigastric region, left and right hypochondriac region.

Trial locations and contacts

1 site in 1 country.

Belgium1 site
  • Cardiac rehabilitation centre at the Jessa Hospital Hasselt

    Hasselt, Limburg, 3500

Other trials in Belgium

About this study

Official title: Effect of Osteopathy on Pulmonary Function in Patients After Coronary Artery Bypass Graft Surgery: a Randomized Controlled Trial

The purpose of this study is to determine the short and long term effects of osteopathic treatment on pulmonary function, pain and quality of life in patients after coronary artery bypass graft (CABG) surgery. The study is a randomized controlled trial.

Read the detailed description

Coronary artery bypass graft (CABG) surgery is performed worldwide. Several studies have found that there is a decrease in pulmonary function, loss of thoracic mobility and a high prevalence of chronic poststernotomy pain (CPSP) after CABG. So far there is no effective treatment for these conditions. The OstinCare study aims to investigate whether osteopathic treatment has an added value in the treatment of these patients.

Being tested
Usual care, Osteopathic treatment
Keywords
Coronary Artery Bypass Graft, Osteopathic Medicine, Vital Capacity, Quality of Life, Cardiac rehabilitation
Medical subject headings
Respiratory Insufficiency, Pain

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Usual careOther

    Also called Outpatient cardiac rehabilitation

    Patients exercise at a heart rate corresponding to 65% of baseline Vo2peak. Each exercise training session takes 40-60 minutes. Exercise time is apportioned as follows: 42% on the treadmill, 33% on the circle ergometer and 25% on the arm cranking device. All patients exercise under close supervision 3 days per week for a total duration of 12 weeks.

  • Osteopathic treatmentOther

    Patients receive 4 osteopathic treatments (OT). OT is performed in week 4, 5, 8 and 12 postoperative. Depending on what is found in the patient, treatments consist mostly of one or more of the following approaches:

    • Structural High Velocity Low Amplitude-techniques.
    • Muscle Energy Techniques.
    • General osteopathic mobilisations.
    • Functional techniques (Sutherland-, Jones-techniques,…) including inhibition techniques.
    • Fascia techniques.
    • Soft tissue- and connective tissue techniques.
    • Neurovisceral and neurolymphatic reflex techniques.
    • Fluidal techniques (lymphatic manipulative techniques,...).
    • Visceral manipulations.
    • Neurocranial and viscerocranial techniques.
Study groups in NCT01714791
Study groupRoleWhat they receive
Usual careActive comparatorPatients following the outpatient cardiac rehabilitation program.
Receives: Other: Usual care
Usual care and Osteopathic treatmentExperimentalPatients following the outpatient cardiac rehabilitation program and receiving osteopathic treatment.
Receives: Other: Usual care; Other: Osteopathic treatment

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Change from baseline in slow vital capacity (SVC) at 12 weeks.

    A Slow Vital Capacity (SVC) test will be performed at each time point.

    Measured: preoperative (baseline) and 12 weeks postoperative

Secondary outcomes (7)
  1. Change from baseline in slow vital capacity (SVC) at 52 weeks.

    A SVC test will be performed at each time point.

    Measured: preoperative (baseline) and 52 weeks postoperative

  2. Change from baseline in McNew quality of life questionnaire at 12 weeks.

    McNew questionnaire will be done at 3 and 12 weeks after surgery.

    Measured: 3 weeks postoperative (baseline) and 12 weeks postoperative

  3. Change from baseline in McNew quality of life questionnaire at 52 weeks.

    McNew questionnaire will be done at 3, 12 and 52 weeks after surgery.

    Measured: 3 weeks postoperative (baseline) and 52 weeks postoperative

  4. Change in pain from baseline on Visual Analogue Scale (VAS) at 12 weeks postoperative.

    Pain will be evaluated at 3 and 12 weeks after surgery.

    Measured: 3 weeks postoperative (baseline) and 12 weeks postoperative

  5. Change in pain from baseline on VAS at 52 weeks postoperative.

    Pain will be evaluated at 3, 12 and 52 weeks after surgery.

    Measured: 3 weeks postoperative (baseline) and 52 weeks postoperative

  6. Change in thoracic stiffness from baseline on VAS at 12 weeks postoperative.

    Thoracic stiffness will be evaluated at 3, 12 weeks after surgery.

    Measured: 3 weeks postoperative (baseline) and 12 weeks postoperative

  7. Change in thoracic stiffness from baseline on VAS at 52 weeks postoperative.

    Thoracic stiffness will be evaluated at 3, 12 and 52 weeks after surgery.

    Measured: 3 weeks postoperative (baseline) and 52 weeks postoperative

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted26 Oct 2012 (estimated)
  2. Study startJan 2010
  3. Primary completionDec 2017
  4. Study completionDec 2017

Why it stopped: Lack of new inclusions due to a significant change in surgery technique. An endoscopic a-traumatic coronary artery bypass (endo-ACAB) approach is now used.

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Parallel groups
Masking
Single blind
Who is masked
Outcomes assessor
Enrolment
112 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT01714791
Sponsor's protocol ID
09.07/cardio09.01
Acronym
OSTinCARE
Status last verified
Mar 2018
First submitted
18 Oct 2012
Last updated
5 Mar 2018
Results posted
No
Data monitoring committee
No

Publications

  • Kristjansdottir A, Ragnarsdottir M, Hannesson P, Beck HJ, Torfason B. Chest wall motion and pulmonary function are more diminished following cardiac surgery when the internal mammary artery retractor is used. Scand Cardiovasc J. 2004 Dec;38(6):369-74. doi: 10.1080/14017430410016396.

    PubMed 15804805
  • Kristjansdottir A, Ragnarsdottir M, Hannesson P, Beck HJ, Torfason B. Respiratory movements are altered three months and one year following cardiac surgery. Scand Cardiovasc J. 2004 May;38(2):98-103. doi: 10.1080/14017430410028492.

    PubMed 15204235
  • Ragnarsdottir M, Kristinsdottir EK. Breathing movements and breathing patterns among healthy men and women 20-69 years of age. Reference values. Respiration. 2006;73(1):48-54. doi: 10.1159/000087456. Epub 2005 Aug 11.

    PubMed 16106113
  • Ragnarsdottir M, KristjAnsdottir A, Ingvarsdottir I, Hannesson P, Torfason B, Cahalin L. Short-term changes in pulmonary function and respiratory movements after cardiac surgery via median sternotomy. Scand Cardiovasc J. 2004 Mar;38(1):46-52. doi: 10.1080/14017430310016658.

    PubMed 15204247
  • Bruce J, Drury N, Poobalan AS, Jeffrey RR, Smith WC, Chambers WA. The prevalence of chronic chest and leg pain following cardiac surgery: a historical cohort study. Pain. 2003 Jul;104(1-2):265-73. doi: 10.1016/s0304-3959(03)00017-4.

    PubMed 12855337
  • Kalso E, Mennander S, Tasmuth T, Nilsson E. Chronic post-sternotomy pain. Acta Anaesthesiol Scand. 2001 Sep;45(8):935-9. doi: 10.1034/j.1399-6576.2001.450803.x.

    PubMed 11576042
  • Locke TJ, Griffiths TL, Mould H, Gibson GJ. Rib cage mechanics after median sternotomy. Thorax. 1990 Jun;45(6):465-8. doi: 10.1136/thx.45.6.465.

    PubMed 2392792
  • Mazzeffi M, Khelemsky Y. Poststernotomy pain: a clinical review. J Cardiothorac Vasc Anesth. 2011 Dec;25(6):1163-78. doi: 10.1053/j.jvca.2011.08.001. Epub 2011 Sep 29. No abstract available.

    PubMed 21955825
  • Meyerson J, Thelin S, Gordh T, Karlsten R. The incidence of chronic post-sternotomy pain after cardiac surgery--a prospective study. Acta Anaesthesiol Scand. 2001 Sep;45(8):940-4. doi: 10.1034/j.1399-6576.2001.450804.x.

    PubMed 11576043
  • van Gulik L, Janssen LI, Ahlers SJ, Bruins P, Driessen AH, van Boven WJ, van Dongen EP, Knibbe CA. Risk factors for chronic thoracic pain after cardiac surgery via sternotomy. Eur J Cardiothorac Surg. 2011 Dec;40(6):1309-13. doi: 10.1016/j.ejcts.2011.03.039. Epub 2011 May 10.

    PubMed 21561786
  • van Leersum NJ, van Leersum RL, Verwey HF, Klautz RJ. Pain symptoms accompanying chronic poststernotomy pain: a pilot study. Pain Med. 2010 Nov;11(11):1628-34. doi: 10.1111/j.1526-4637.2010.00975.x.

    PubMed 21044253
  • Westerdahl E, Lindmark B, Bryngelsson I, Tenling A. Pulmonary function 4 months after coronary artery bypass graft surgery. Respir Med. 2003 Apr;97(4):317-22. doi: 10.1053/rmed.2002.1424.

    PubMed 12693792
  • Hansen D, Dendale P, Berger J, Meeusen R. Rehabilitation in cardiac patients:what do we know about training modalities? Sports Med. 2005;35(12):1063-84. doi: 10.2165/00007256-200535120-00005.

    PubMed 16336009
  • Alston RP, Pechon P. Dysaesthesia associated with sternotomy for heart surgery. Br J Anaesth. 2005 Aug;95(2):153-8. doi: 10.1093/bja/aei152. Epub 2005 May 13.

    PubMed 15894562
  • Miller MR, Hankinson J, Brusasco V, Burgos F, Casaburi R, Coates A, Crapo R, Enright P, van der Grinten CP, Gustafsson P, Jensen R, Johnson DC, MacIntyre N, McKay R, Navajas D, Pedersen OF, Pellegrino R, Viegi G, Wanger J; ATS/ERS Task Force. Standardisation of spirometry. Eur Respir J. 2005 Aug;26(2):319-38. doi: 10.1183/09031936.05.00034805. No abstract available.

    PubMed 16055882

Questions about this trial

What is this clinical trial studying?

A study testing Osteopathic treatment in people with Mechanical Complication of Coronary Artery Bypass Graft and Respiratory Depression, run by Hartcentrum Hasselt at 1 site in Belgium.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 3 inclusion and 6 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: stopped early, as of the sponsor's last update on 5 Mar 2018. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Belgium. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study was stopped early (reason given: Lack of new inclusions due to a significant change in surgery technique. An endoscopic a-traumatic coronary artery bypass (endo-ACAB) approach is now used.). Results are not available in the source record.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Change from baseline in slow vital capacity (SVC) at 12 weeks. (time frame: preoperative (baseline) and 12 weeks postoperative). It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT01714791, which also lists 17 linked publications.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 5 Mar 2018.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in